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Abstract 
Hypertension is a worldwide health problem affecting developed and developing countries, and Pakistan is no exception. Nishtar 
Hospital Multan is categorized as one of the biggest hospitals in South Asia. The objective for this study was to describe medication 
decision-making, dispensing, and utilization for patients diagnosed with hypertension at this patient care facility. The study was 
conducted by 5 trained pharmacists working in collaboration with prescribers who met with study participants when they visited the 
hospital. All interview questions were asked in Urdu during the hospital visit. Data were summarized using descriptive statistics. A 
total of 301 patients who visited the hospital agreed to participate in the study. The findings showed that prescribers spend little time 
with patients and rarely follow guidelines for decision-making. Regarding the dispensing of medications for the treatment of 
hypertension, none of the dispensing was completed by a pharmacist and none of the patients received counseling about medications 
at the time of dispensing. Most patients reportedly do not take their medication as prescribed. Regarding outcomes, 20% of the 
patients had pre-hypertension, 47% stage 1 hypertension, and 33% stage 2 hypertension. Great improvements are possible in the 
treatment of hypertension at the hospital we studied through application of standard treatment guidelines, patient education, and 
adjustments to work system processes so that alignment of provider’s skills with opportunities in improving the patient care process 
can be achieved. 
 
 
Introduction 
The World Health Organization (WHO) has defined the term 
rational drug use as “where patients receive medications 
appropriate to their clinical needs, in doses that meet their 
own individual requirements for an adequate period of time, 
and at the lowest cost to them and their community” [1]. 
Regarding the rational use of drugs, WHO mentions 12 key 
interventions to encourage the rational use of drugs [1]. 
These key points are: (1) establishment of a multidisciplinary 
national body to coordinate policies on medicine use, (2) use 
of clinical guidelines, (3) development and use of a national 
essential medicines list, (4) establishment of drug and 
therapeutics committees in districts and hospitals, (5) 
inclusion of problem-based pharmacotherapy training in 
undergraduate curricula, (6) continuing in-service medical 
education as a licensure requirement, (7) supervision, audit 
and feedback, (8) use of independent information on 
medicines, (9) public education about medicines, (10) 
avoidance of perverse financial incentives, (11) use of 
appropriate and enforced regulation, and (12) sufficient  
government expenditure to ensure availability of medicines 
and staff.                                        
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Hypertension is a worldwide health problem affecting 
developed and developing countries, and Pakistan is no 
exception [2-13]. Hypertension is associated with a number 
of problems and is the most common risk factor for 
cardiovascular disease in all population groups in Pakistan. 
Pakistan has the world's sixth largest population (165 million 
in 2007) which is continuously growing at about 1.83% every 
year. We know from our national heath surveys that 33% of 
the Pakistani population above the age of 45 has 
hypertension [5]. According to a study conducted in 2009 in 
Nishtar Hospital Multan Pakistan, Institute of cardiology 
Multan Pakistan and Sheikh Zayed hospital Rahim Yar Khan 
Pakistan, 70% of patients with heart disease were males and 
45% of patients were diagnosed with hypertension [5, 13].                                                                                  
 
Nishtar Hospital Multan is categorized as one of the biggest 
hospitals in South Asia. The objective for this study was to 
describe medication decision-making, dispensing, and 
utilization for patients diagnosed with hypertension at this 
patient care facility. This prospective study of 3 months 
ranging from the month of June 2011 to September 2011 was 
conducted in Nishtar Hospital Multan Pakistan. 
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Methods 
Ethical Approval and Informed Consent 
Patients who committed to participate in the study were 
explained the nature as well as objectives lying behind the 
study and their informed consent formally obtained. For 
patients who were underage, informed consent was obtained 
from their parents/guardians. 
 
Data Collection 
The study was conducted by 5 trained pharmacists working in 
collaboration with prescribers who met with study 
participants when they visited the hospital. All interview 
questions were asked in Urdu during the hospital visit. 
 
The Questionnaire 
The overall questionnaire consisted of 34 questions and was 
completed by the trained pharmacist in collaboration with 
feedback from patients and physicians. Questions that were 
used for the preparation of this report included demographic 
data about each patient’s age, gender, body mass index, 
weight, location of residence, occupation, and socioeconomic 
class. Other information was collected using the 
questionnaire and included information about:  
 Length of time prescribers spent with patients during 
the visit 
 Prescriber use of generic name of medications 
during prescribing 
 Prescriber use of JNC7 guidelines for treatment of 
hypertension 
 Prescriber awareness of the hospital’s drug 
formulary  
 Prescriber agreement that a standard treatment 
protocol should be followed for treatment of 
hypertension 
 Type of Professional (pharmacist or nurse) who 
dispensed the hypertension medication to the 
patient 
 Patient receipt of counseling from the dispenser at 
time of hypertension medication dispensing 
 Patient self-reported adherence to hypertension 
medication as prescribed 
 Blood pressure status at time of visit 
 Pulse rate at time of visit 
 
Data Analysis 
Data were summarized using descriptive statistics.  
Results 
A total of 301 patients who visited the hospital agreed to 
participate in the study. Table 1 summarizes the demographic 
characteristics of the study participants. Fifty-four percent of 
the participants were age 50 or older and 57% of the 
participants were female. There was variation amongst 
participants in terms of body mass index, and weight. 
Socioeconomic class for the majority of study participants 
was described as “Poor.” 
 
The findings showed that prescribers almost always spent less 
than 10 minutes with each patient (Table 2). Prescribers 
rarely (<1%) used generic names of medications when 
prescribing, rarely (3%) followed guidelines for decision-
making, and only 2% reported knowing that the hospital had 
a drug formulary for making prescribing decisions for 
medications to use in treating hypertension. When asked 
about if the hospital should use a standard treatment 
protocol for prescribers to follow when making prescribing 
decisions for treatment of hypertension, 95% reported that 
they agreed. 
 
Regarding the dispensing of medications for the treatment of 
hypertension, none of the dispensing was completed by a 
pharmacist and none of the patients received counseling 
about medications at the time of dispensing. 
 
Regarding self-reported adherence to their medications for 
treatment of hypertension, 54% of patients reported that 
they do not take the medication as prescribed. Regarding 
outcomes, 20% of the patients had pre-hypertension, 47% 
stage 1 hypertension, and 33% stage 2 hypertension. Also, 
71% of the patients had a pulse rate 80 beats per minute or 
higher during their hospital visit. 
 
Discussion 
We propose that there is great opportunity for improvement 
in the treatment of patients with hypertension at Nishtar 
Hospital Multan, Pakistan. The majority of patients in our 
study were age 50 and older. With the advancement in age, 
patients may be more inclined to forget their dosing schedule 
which creates grave effects on the health of the patient. In 
the absence of any care taker, the condition of the patient 
may become grimmer. Also an increase in dosage frequency 
and number of drugs to be taken per day may cause 
problems. A patient’s geographic location of residence, 
occupation, and socioeconomic class creates an impact of the 
treatment of hypertension. People residing in urban areas 
may run short of pure and low caloric food and many rely on 
junk and high caloric food. Weight gain and physical inactivity 
are important considerations in the treatment of 
hypertension. More than 70% of all hypertensive patients 
(85% in rural areas) in Pakistan are not even aware of their 
disease [5, 13]. This creates geographic location challenges. 
With respect to socioeconomic class and hypertension, both 
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the rich and poor people are equally affected. However, the 
dilemma associated with poor people is that most of them 
are not aware of having hypertension and they get aware of 
suffering from hypertension on having an attack of angina 
pectoris, or stroke which on most of the occasions prove fatal 
to life [5, 13].  
 
The findings also showed that little time was spent with 
patients during the prescribing process, and no consultation 
was given patients regarding medication use. Furthermore, 
prescribers and dispensers of medications for treatment of 
hypertension did not utilize any protocols for prescribing and 
dispensing of these products. We propose that there is an 
opportunity for improving the prescribing and dispensing of 
medications for hypertension through the use and application 
of generic drug use, prescribing guidelines, formularies, 
pharmacist dispensing of medications, and appropriate 
patient consultation and follow-up by pharmacists.  
 
Heavy work-loads that already exist, lack of awareness by 
prescribers and dispensers about guidelines already in place, 
the lack of clear work system processes for prescribing and 
dispensing medications, and lack of alignment of providers 
skills with opportunities in improving the patient care process 
area challenges that need to be overcome.  
 
Conclusions and Recommendations 
We suggest that great improvements are possible in the 
treatment of hypertension at the hospital we studied. We 
offer a few recommendations for further discussion and 
consideration: 
 Patient care providers should take careful note of 
patients’ perceptions and goals, any adverse effects 
being experienced, drug interactions, any past 
medications that were used for hypertension, and a 
complete detail of patients’ medication use. 
 Apart from pharmacological treatment, non-
pharmacological treatments are equally imperative 
in the suppression of hypertension. Those non 
pharmacological treatments for suppression of 
hypertension include reduced salt intake, low caloric 
and protein diet and physical activity of an 
appropriate level.  
 Patient education plays an important role in 
promoting rational use of drugs. One way to educate 
patients about the rational use of drugs is through 
individual communication during the contact 
between providers and patients. 
 Application of standard treatment guidelines should 
be followed. 
 
 Work system processes for prescribing and 
dispensing medications should be changed so that 
alignment of provider’s skills with opportunities in 
improving the patient care process can be achieved. 
 
 
References 
1. Rational drug use: prescribing, dispensing, 
counseling and adherence in ART programs; revised 
06/2011; available at 
http://www.whoint/hiv/amds/capacity/ken_msh_ra
tional .pdf 
2. Carretero, Oscar A., and Suzanne Oparil. "Essential 
hypertension part I: definition and 
etiology." Circulation 101.3 (2000): 329-335. 
3. Chobanian, Aram V., George L. Bakris, Henry R. 
Black, William C. Cushman, Lee A. Green, Joseph L. 
Izzo, Daniel W. Jones et al. "Seventh report of the 
joint national committee on prevention, detection, 
evaluation, and treatment of high blood 
pressure." Hypertension 42, no. 6 (2003): 1206-1252. 
4. Kearney, Patricia M., Megan Whelton, Kristi 
Reynolds, Paul Muntner, Paul K. Whelton, and Jiang 
He. "Global burden of hypertension: analysis of 
worldwide data." The Lancet 365, no. 9455 (2005): 
217-223. 
5. Jafar, Tazeen H., Andrew S. Levey, Fahim H. Jafary, 
Franklin White, Asma Gul, Mohammad H. Rahbar, 
Abdul Q. Khan, Andrew Hattersley, Christopher H. 
Schmid, and Nish Chaturvedi. "Ethnic subgroup 
differences in hypertension in Pakistan." Journal of 
hypertension 21, no. 5 (2003): 905-912. 
6. Inkster, M. E., P. T. Donnan, T. M. MacDonald, F. M. 
Sullivan, and T. Fahey. "Adherence to 
antihypertensive medication and association with 
patient and practice factors." Journal of human 
hypertension 20, no. 4 (2006): 295-297. 
7. Osterberg, Lars, and Terrence Blaschke. "Adherence 
to medication." New England Journal of 
Medicine 353.5 (2005): 487-497. 
8. Youssef, R. M., and I. I. Moubarak. "Patterns and 
determinants of treatment compliance among 
hypertensive patients." East Mediterr Health J 8, no. 
4-5 (2002): 579-92. 
9. Cheng, Judy WM, Michelle M. Kalis, and Stanley 
Feifer. "Patient‐Reported Adherence to Guidelines of 
the Sixth Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood 
Pressure."Pharmacotherapy: The Journal of Human 
Pharmacology and Drug Therapy 21, no. 7 (2001): 
828-841. 
Case Study PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                      2013, Vol. 4, No. 4, Article 134                          INNOVATIONS in pharmacy   4 
 
10. Yiannakopoulou, Eugenia Ch, John S. Papadopulos, 
Dennis V. Cokkinos, and Theodoros D. 
Mountokalakis. "Adherence to antihypertensive 
treatment: a critical factor for blood pressure 
control." European Journal of Cardiovascular 
Prevention & Rehabilitation 12, no. 3 (2005): 243-
249. 
11. Monane, Mark, Rhonda L. Bohn, Jerry H. Gurwitz, 
Robert J. Glynn, Raisa Levin, and Jerry Avorn. "The 
Effects of Initial Drug Choice and Comorbidity on 
Antihypertensive Therapy Compliance: Results from 
a Population-Based Study in the Elderly." American 
Journal of Hypertension10, no. 7 (1997): 697-704. 
12. Ghaffar, Abdul, K. Srinath Reddy, and Monica Singhi. 
"Burden of non-communicable diseases in South 
Asia." BMJ: British Medical Journal 328, no. 7443 
(2004): 807. 
13. Jafar, Tazeen H., Fahim H. Jafary, Saleem Jessani, and 
Nish Chaturvedi. "Heart disease epidemic in 
Pakistan: women and men at equal risk. “American 
heart journal 150, no. 2 (2005): 221-226. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Case Study PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                      2013, Vol. 4, No. 4, Article 134                          INNOVATIONS in pharmacy   5 
 
Table 1: Descriptive Summary for Study Participants (N = 301) 
 
Variable Frequency Percent 
Age 
Under 30 years 
30 to 49 years 
50 to 59 years 
60 years or older 
 
19 
120 
86 
76 
 
6% 
40% 
29% 
25% 
Gender 
Male 
Female 
 
130 
171 
 
43% 
57% 
Body Mass Index 
Less than 18.5 
18.5 to 24.9 
25.0 to 29.9 
30.0 or more 
 
30 
166 
80 
25 
 
10% 
55% 
27% 
8% 
Weight (in kilograms) 
Under 60 Kg 
60 to 70 Kg 
More than 70 Kg 
 
108 
151 
42 
 
36% 
50% 
14% 
Location of Residence (city name) 
Multan 
Khanewal 
Liyyah 
Chowkazam 
D.G. Khan 
Rahim Yar Khan 
Shujabad 
Others 
 
125 
30 
25 
24 
24 
20 
5 
48 
 
42% 
10% 
8% 
8% 
8% 
7% 
2% 
16% 
Occupation 
Homemaker 
Laborer 
None 
Worker 
Agriculture 
Business 
Gardener 
Other 
 
130 
46 
42 
33 
18 
7 
4 
21 
 
43% 
15% 
14% 
11% 
6% 
2% 
1% 
7% 
Socioeconomic Class 
Rich 
Ordinary 
Poor 
 
8 
110 
183 
 
3% 
37% 
61% 
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Table 2: Descriptive Summary for Clinic Visit (N = 301) 
 
Variable Frequency Percent 
Length of Time Prescribers Spent with Patients 
Less than 10 minutes 
10 minutes or more 
 
295 
6 
 
98% 
2% 
Proportion of Prescribers who Prescribe Using 
Generic Name of Medications 
 
1 
 
<1% 
Proportion of Prescribers who Followed JNC7 
Guidelines for Treatment of Hypertension 
 
10 
 
3% 
Proportion of Prescribers Who were Aware of Drug 
Formulary 
 
7 
 
2% 
Proportion of Prescribers Who Agreed that a 
Standard Treatment Protocol should be Followed for 
Treatment of Hypertension 
 
286 
 
95% 
Professional who served as Dispenser of 
Hypertension Medication 
Nurse 
Pharmacist 
 
 
301 
0 
 
 
100% 
0% 
Proportion of Patients who Received Counseling 
about Medications at Time of Dispensing 
 
0 
 
0% 
Proportion of Patients who Reported they Do Not 
Take the Medication as Prescribed 
 
164 
 
54% 
Blood Pressure Status 
Prehypertension (SBP 130-139 or DBP 85-89) 
Stage 1 Hypertension (SBP 140-159 or DBP 90-99) 
Stage 2 Hypertension (SBP 160+ or DBP 100+) 
 
59 
142 
100 
 
20% 
47% 
33% 
Pulse Rate (beats per minute) 
Less than 80 
80 to 109 
110 or higher 
 
87 
207 
7 
 
29% 
69% 
2% 
 
